American Association for the Advancement of Science, Science Translational Medicine, 395(9), 2017
DOI: 10.1126/scitranslmed.aam5434
Full text: Unavailable
Individual human VP4- and VP7-binding monoclonal antibodies mediate serotype cross-reactive neutralizing immunity to rotaviruses.